3.64BMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-06-18The current institutional shareholding score of Denali Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 100.01%, representing a quarter-over-quarter decrease of 4.50%. The largest institutional shareholder is ETHSX, holding a total of 390.90K shares, representing 0.26% of shares outstanding, with 1.00% increase in holdings.
Institutional Shareholding
Shareholder Activity
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
Temasek Holdings Pte. Ltd.
State Street Investment Management (US)
Norges Bank Investment Management (NBIM)
Fidelity Management & Research Company LLC